supp.fit

Riboflavin, Vitamin A and Iron: study protocols

8 study groups took Riboflavin together with Vitamin A and Iron. These are the doses the studies gave. They are not a recommendation.

Riboflavin: what the research found →

Dose per serving from research: Riboflavin

8 study groups in 8 studies say how much Riboflavin participants took a day.

These are the doses the studies gave. They are not a recommendation.

Most common: 1 mg to 2.5 mg, 50% of 8 study groups.

Daily doseStudy groups
500 mcg or less
1
500 mcg to 1 mg
1
1 mg to 2.5 mg
4
2.5 mg to 5 mg
0
5 mg to 10 mg
1
10 mg to 25 mg
0
25 mg to 50 mg
0
50 mg to 100 mg
0
100 mg to 250 mg
0
250 mg to 500 mg
1

Dose per serving from research: Vitamin A

7 study groups in 7 studies say how much Vitamin A participants took a day.

These are the doses the studies gave. They are not a recommendation.

Most common: 500 mcg to 1 mg, 57% of 7 study groups.

Daily doseStudy groups
250 mcg to 500 mcg
2
500 mcg to 1 mg
4
1 mg to 2.5 mg
1

Dose per serving from research: Iron

6 study groups in 6 studies say how much Iron participants took a day.

These are the doses the studies gave. They are not a recommendation.

Most common: 5 mg to 10 mg and 25 mg to 50 mg, 33% of 6 study groups each.

Daily doseStudy groups
1 mg or less
1
1 mg to 2.5 mg
0
2.5 mg to 5 mg
0
5 mg to 10 mg
2
10 mg to 25 mg
1
25 mg to 50 mg
2

Commonly used together

6 of 8 study groups took Riboflavin, Vitamin A and Iron with something else. Shown: what 3 or more different studies gave. The 10 most common of 12.

What was given together, not what works together.

Taken withStudy groups
Vitamin B12
6
Vitamin E
6
Zinc
6
Copper
5
Niacin
5
Vitamin B6
5
Folic Acid
4
Iodine
4
Selenium
4
Thiamine
4

8 study groups

Study
Effects of multimicronutrient supplementation on helminth reinfection: a randomized, controlled trial in Kenyan schoolchildren
2003 · multimicronutrient supplementation · Schoolchildren in Nyanza Province, Kenya; age and sex not specified
1.6 mg1 mg18 mg335 days—
Effects of maternal micronutrient supplementation on fetal loss and infant mortality: a cluster-randomized trial in Nepal
2003 · Multiple micronutrients · Pregnant women in rural Nepal
1.8 mg1 mg———
Improvement of migraine symptoms with a proprietary supplement containing riboflavin, magnesium and Q10: a randomized, placebo-controlled, double-blind, multicenter trial
2015 · Verum (investigational nutritional product) · Adults aged 18–65 of either sex with migraine with or without aura, and at least 3 migraine attacks per month before recruitment
400 mg750 mcg800 mcg90 days63
Supplementation with iron and riboflavin enhances dark adaptation response to vitamin A-fortified rice in iron-deficient, pregnant, nightblind Nepali women
2007 · FeR + VA · Pregnant Nepali women with nightblindness; the reported pupillary-threshold subgroup was iron-deficient at baseline
6 mg850 mcg30 mg6 weeks—
Daily supplementation of a multiple micronutrient powder improves folate but not thiamine, riboflavin, or vitamin B(12) status among young Laotian children: a randomized controlled trial
2022 · micronutrient powder group (MNP) · Children aged 6–23 months in rural Lao PDR; no disease-based selection, with high prevalence of undernutrition and micronutrient deficiencies
500 mcg400 mcg6 mg36 weeks130
Assessment of vitamin A, vitamin B(2), vitamin B(12), vitamin K, folate, and choline status following 4 months of multinutrient supplementation in healthy vegans: a randomised, double-blind, placebo-controlled trial
2025 · INT (intervention group; standard and double omega-3 dosage subgroups) · Healthy adults aged 18 years or older who had followed a vegan diet for at least 1 year; no diagnosed vitamin or mineral deficiency
1.4 mg500 mcg6 mg120 days35
Supplementation of iron alone and combined with vitamins improves haematological status, erythrocyte membrane fluidity and oxidative stress in anaemic pregnant women
2010 · group IM · Pregnant women with anaemia
1 mg2 mg—60 days—
A novel nutritional supplement to reduce plasma homocysteine in nonpregnant women: A randomised controlled trial in The Gambia
2019 · UNIMMAP tablet · Nonpregnant, non-lactating healthy women aged 18–45 years in West Kiang, The Gambia; women of reproductive age with common micronutrient deficiencies in the population
1.4 mg—30 mg12 weeks105